ARTICLE | Company News
Eli Lilly, Kyowa Hakko Kogyo Co. Ltd. deal
January 30, 2006 8:00 AM UTC
Kyowa granted LLY exclusive worldwide rights, except in Japan, to develop and sell a preclinical kinesin-related motor protein ( Eg5) inhibitor. The companies will share rights to the cancer compound ...